We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.

CRISPR and bioengineering are hot topics from our Cell + Gene Curator roundup.

After years of speculation, we reveal what Brexit really means for pharma – so far.

And the winner of The Medicine Maker 2020 Innovation Awards is…

What is the single greatest challenge facing the cell and gene therapy industry in 2021?

When it comes to clinical trials, is pharma making the best use of digital technologies?

Sputnik V (finally and definitely) starts rolling review with the EMA.

Does pharma really need to pay a high price when it comes to synthetic chemistry?

High-level purification maximizes the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction.

How to add value and reduce risks with ethics.